Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2022 Earnings Call Transcript November 14, 2022
Acurx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.32 EPS, expectations were $-0.28.
Operator: Greetings. Welcome to Acurx Pharmaceuticals, Inc. to Discuss 2022 Third Quarter Financial Results on November 14, 2022. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. . As a reminder, this...
